Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Citius Pharmaceuticals Inc (CTXR)

Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Citius Pharmaceuticals Inc 11 Commerce Drive First Floor Cranford NJ 07016 USA

www.citiuspharma.com Employees: 23 P: 908-967-6677

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care and prescription products. Citius Pharmaceuticals, Inc. is headquartered in Cranford, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 17,815
Enterprise Value, $K 13,565
Shares Outstanding, K 20,763
Float, K 18,541
% Float 89.30%
Short Interest, K 2,628
Short Float 12.66%
Days to Cover 7.10
Short Volume Ratio 0.30
% of Insider Shareholders 10.70%
% of Institutional Shareholders 16.88%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -37,430 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,960 K
EBIT, $ -38,530 K
EBITDA, $ -38,320 K

Growth:

1-Year Return -73.68%
3-Year Return -97.51%
5-Year Return -97.28%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 69.96%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.80 on 08/12/25
Next Earnings Date 02/13/26 [--]
Earnings Per Share ttm -3.37
EPS Growth vs. Prev Qtr 37.01%
EPS Growth vs. Prev Year 46.67%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 11/26/24

CTXR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -55.93%
Return-on-Assets % -31.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.19
Book Value/Share 4.56
Interest Coverage -142.26
60-Month Beta 1.56
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar